In Re: National Prescription Opiate Litigation

Track this case

Case Number:

1:17-md-02804

See also:

Court:

Ohio Northern

Nature of Suit:

P.I.: Other

Multi Party Litigation:

Class Action, Multi-district Litigation

Judge:

Dan Aaron Polster (MDL 28

Firms

Companies

Government Agencies

Sectors & Industries:

  1. July 01, 2019

    Opioid MDL Litigants Seek Triumphs Before Bellwether Trial

    As a bellwether trial nears in multidistrict opioid litigation, drug companies and Ohio local governments are seeking victories on crucial legal questions over liability for a deadly addiction epidemic and a proposed multibillion-dollar remedy.

  2. June 25, 2019

    Opioid MDL Judge Seems Open To Novel Deal Approach

    The Ohio federal judge overseeing the opioid multidistrict litigation appeared receptive Tuesday to an inventive proposal to create a class of local governments to negotiate a global settlement with drug companies accused of fueling the addiction crisis, saying novel problems need novel solutions.

  3. June 24, 2019

    'Negotiating Class' Bid Slammed In Opioid MDL

    Drug distributors, pharmacies and state attorneys general on Monday launched a salvo against a novel bid by local governments in the opioid multidistrict litigation to create a "negotiating class" to seek a global settlement of claims that drug companies fueled the opioid crisis.

  4. June 21, 2019

    Biggest Health And Life Sci Rulings Of 2019: Midyear Report

    The first half of 2019 saw an extraordinary eruption of important court decisions likely to leave lasting marks on the opioid crisis, the False Claims Act, the Affordable Care Act and Medicare reimbursement. Here, Law360 takes stock of consequential health care and life sciences rulings that lawyers need to know.

  5. June 14, 2019

    3 Takeaways As 'Negotiation Class' Idea Jolts Opioid MDL

    An unconventional move Friday to resolve multidistrict opioid litigation by unifying local governments in a “negotiation class” could be an inflection point for the bruising legal slugfest targeting drug companies, although class certification isn’t a sure thing. Here, Law360 explores three key takeaways from the high-stakes maneuver.

  6. June 14, 2019

    'Negotiation Class' May Tee Up Sweeping Deal In Opioid MDL

    Local governments in the multidistrict opioid litigation on Friday launched an unusual effort to create a "negotiation class" of cities and counties that would seek a global settlement with drug companies accused of igniting a nationwide firestorm of addiction.

  7. June 12, 2019

    Shoshone Tribe Joins Opioid MDL, Details Epidemic's Impact

    The Eastern Shoshone Tribe announced on Tuesday that it is joining a national multidistrict litigation seeking to hold pharmaceutical companies responsible for the country's opioid epidemic, alleging that the drugs have hit Native American nations particularly hard.

  8. May 08, 2019

    BakerHostetler Fights 'Indefensible' DQ In Opioid MDL

    BakerHostetler on Wednesday asked the Sixth Circuit to vacate an Ohio judge's decision to disqualify the firm from representing Endo Pharmaceuticals in two bellwether cases in the multidistrict opioid litigation, saying the decision will affect the entire MDL.

  9. April 26, 2019

    Atty Sanctions Axed In Opioid MDL, Allowing Doc's Testimony

    An Ohio federal judge on Friday scrapped attorney sanctions that would have barred testimony from a high-profile pain doctor in the multidistrict opioid litigation, calling the discipline "too extreme" despite a galling failure by plaintiffs' attorneys to divulge a deal with the doctor.

  10. April 25, 2019

    Opioid MDL Attys' Concealment Merited Sanction: Drug Cos.

    Plaintiffs' attorneys who hid key witness testimony in the multidistrict opioid litigation were properly sanctioned by having that testimony blocked from a bellwether trial, drug companies told an Ohio federal court on Thursday.